SAN FRANCISCO--(BUSINESS WIRE)--Omada Health, a pioneer in the emerging field of digital therapeutics, today announced the National Association of Chronic Disease Directors (NACDD) has selected its flagship product, Prevent, an online program to fight prediabetes, as a premier solution for patients seeking an online Diabetes Prevention Program (DPP).
“The NACDD’s endorsement of Prevent is a tremendous validation of how digital therapeutics can revolutionize behavioral medicine and help combat chronic disease at scale”
The mission of the NACDD is to work with public health departments, associations and private partners across the United States to prevent and control chronic disease. One of NACDD’s areas of focus is the prevention of type 2 diabetes. People with diagnosed diabetes, on average, have medical expenditures approximately 2.3 times higher than those without diabetes. Thirty-seven percent of American adults have prediabetes (the clinical precursor to type 2 diabetes), and without lifestyle changes to improve their health, 15% to 30% of those will develop type 2 diabetes within five years.
Read More: http://www.businesswire.com/news/home/20140715006190/en/Omada-Health-Endorsed-National-Association-Chronic-Disease#.U8bQQvldWsA
Omada Health Endorsed by the National Association of Chronic Disease Directors as a Premier Online Provider for Patients Seeking the Diabetes Prevention Program (DPP)
Via: Business Wire